RS54754B1 - Kristalni oblik argininske soli perindoprila, postupak njene proizvodnje i farmaceutske smeše koje je sadrže - Google Patents
Kristalni oblik argininske soli perindoprila, postupak njene proizvodnje i farmaceutske smeše koje je sadržeInfo
- Publication number
- RS54754B1 RS54754B1 RS20160321A RSP20160321A RS54754B1 RS 54754 B1 RS54754 B1 RS 54754B1 RS 20160321 A RS20160321 A RS 20160321A RS P20160321 A RSP20160321 A RS P20160321A RS 54754 B1 RS54754 B1 RS 54754B1
- Authority
- RS
- Serbia
- Prior art keywords
- perindopril
- crystalline form
- arginine salt
- preparing
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
α kristalni oblik L-argininske soli perindoprila, formule (I):naznačen time što ima sledeće pikove difrakcije X-zrakova praška, koji su izmereni korišćenjem difraktometra sa bakarnom antikatodom i uz Kβ (Ni) filter i, koji su izraženi kao Braggov ugao 2 teta (°): 4.5, 7.9 i 13.5.Prijava sadrži još 11 patentnih zahteva.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0601748A FR2897866B1 (fr) | 2006-02-28 | 2006-02-28 | Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
EP07731039.9A EP1989182B1 (fr) | 2006-02-28 | 2007-02-26 | Forme cristalline du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
PCT/FR2007/000335 WO2007099217A1 (fr) | 2006-02-28 | 2007-02-26 | FORME CRISTALLINE α DU SEL D'ARGININE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT |
Publications (1)
Publication Number | Publication Date |
---|---|
RS54754B1 true RS54754B1 (sr) | 2016-10-31 |
Family
ID=37022969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20160321A RS54754B1 (sr) | 2006-02-28 | 2007-02-26 | Kristalni oblik argininske soli perindoprila, postupak njene proizvodnje i farmaceutske smeše koje je sadrže |
Country Status (28)
Country | Link |
---|---|
US (1) | US7846961B2 (sr) |
EP (1) | EP1989182B1 (sr) |
JP (1) | JP5255454B2 (sr) |
KR (2) | KR20120001818A (sr) |
CN (1) | CN101389603B (sr) |
AU (1) | AU2007220435B2 (sr) |
BR (1) | BRPI0708278B8 (sr) |
CA (1) | CA2644467C (sr) |
CY (1) | CY1117753T1 (sr) |
DK (1) | DK1989182T3 (sr) |
EA (1) | EA014716B1 (sr) |
ES (1) | ES2581982T3 (sr) |
FR (1) | FR2897866B1 (sr) |
GE (1) | GEP20125433B (sr) |
HK (1) | HK1129669A1 (sr) |
HR (1) | HRP20160644T1 (sr) |
HU (1) | HUE027898T2 (sr) |
MA (1) | MA30276B1 (sr) |
ME (1) | ME02456B (sr) |
MY (1) | MY151035A (sr) |
NO (1) | NO20083535L (sr) |
NZ (1) | NZ570367A (sr) |
PL (1) | PL1989182T3 (sr) |
RS (1) | RS54754B1 (sr) |
SI (1) | SI1989182T1 (sr) |
UA (1) | UA89905C2 (sr) |
WO (1) | WO2007099217A1 (sr) |
ZA (1) | ZA200807024B (sr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009157018A2 (en) | 2008-06-24 | 2009-12-30 | Matrix Laboratories Ltd | Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof |
AU2009212902A1 (en) | 2008-09-03 | 2010-03-18 | Apotex Pharmachem Inc. | Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof |
SI23149A (sl) | 2009-09-21 | 2011-03-31 | Silverstone Pharma | Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
FR2985512B1 (fr) * | 2012-01-05 | 2014-06-20 | Servier Lab | Procede de preparation du sel de l-arginine du perindopril |
FR2985511B1 (fr) * | 2012-01-05 | 2014-01-03 | Servier Lab | Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
CN103172696B (zh) * | 2012-12-19 | 2014-12-17 | 宁波美诺华药业股份有限公司 | 一种γ晶型的培哚普利精氨酸盐的制备方法 |
FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
EP3842035A1 (en) | 2019-12-23 | 2021-06-30 | KRKA, d.d., Novo mesto | Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules |
SI26268A (sl) | 2021-11-18 | 2023-05-31 | Zupet Rok | Postopek za pripravo hidratirane oblike perindopril l-arginina |
CN114149357B (zh) * | 2021-12-29 | 2024-06-25 | 江苏嘉逸医药有限公司 | 一种γ晶型培哚普利精氨酸盐的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2503155A2 (fr) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
FR2811320B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2811319B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2811318B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2838648B1 (fr) * | 2002-04-18 | 2004-05-21 | Servier Lab | Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent |
FR2897865B1 (fr) | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
WO2009157018A2 (en) | 2008-06-24 | 2009-12-30 | Matrix Laboratories Ltd | Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof |
-
2006
- 2006-02-28 FR FR0601748A patent/FR2897866B1/fr active Active
-
2007
- 2007-02-26 PL PL07731039.9T patent/PL1989182T3/pl unknown
- 2007-02-26 HU HUE07731039A patent/HUE027898T2/en unknown
- 2007-02-26 JP JP2008556812A patent/JP5255454B2/ja active Active
- 2007-02-26 CA CA2644467A patent/CA2644467C/fr not_active Expired - Fee Related
- 2007-02-26 ES ES07731039.9T patent/ES2581982T3/es active Active
- 2007-02-26 WO PCT/FR2007/000335 patent/WO2007099217A1/fr active Application Filing
- 2007-02-26 ZA ZA200807024A patent/ZA200807024B/xx unknown
- 2007-02-26 US US12/224,369 patent/US7846961B2/en active Active
- 2007-02-26 KR KR1020117028452A patent/KR20120001818A/ko active Search and Examination
- 2007-02-26 KR KR1020087023638A patent/KR20080106948A/ko not_active Application Discontinuation
- 2007-02-26 GE GEAP200710918A patent/GEP20125433B/en unknown
- 2007-02-26 CN CN2007800061889A patent/CN101389603B/zh active Active
- 2007-02-26 BR BRPI0708278A patent/BRPI0708278B8/pt active IP Right Grant
- 2007-02-26 ME MEP-2016-140A patent/ME02456B/me unknown
- 2007-02-26 DK DK07731039.9T patent/DK1989182T3/en active
- 2007-02-26 EA EA200801777A patent/EA014716B1/ru unknown
- 2007-02-26 NZ NZ570367A patent/NZ570367A/en unknown
- 2007-02-26 UA UAA200811436A patent/UA89905C2/ru unknown
- 2007-02-26 SI SI200731781A patent/SI1989182T1/sl unknown
- 2007-02-26 EP EP07731039.9A patent/EP1989182B1/fr not_active Revoked
- 2007-02-26 MY MYPI20082991 patent/MY151035A/en unknown
- 2007-02-26 AU AU2007220435A patent/AU2007220435B2/en active Active
- 2007-02-26 RS RS20160321A patent/RS54754B1/sr unknown
-
2008
- 2008-08-14 NO NO20083535A patent/NO20083535L/no not_active Application Discontinuation
- 2008-09-11 MA MA31232A patent/MA30276B1/fr unknown
-
2009
- 2009-08-24 HK HK09107755.1A patent/HK1129669A1/xx unknown
-
2016
- 2016-06-09 HR HRP20160644TT patent/HRP20160644T1/hr unknown
- 2016-07-11 CY CY20161100654T patent/CY1117753T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS54754B1 (sr) | Kristalni oblik argininske soli perindoprila, postupak njene proizvodnje i farmaceutske smeše koje je sadrže | |
UA83720C2 (ru) | Кристаллическая форма v агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит | |
JO3178B1 (ar) | النموذج السادس البلوري الجديد من مركب الاغوميلاتين وطريقة تحضيره وتحضير المركبات الصيدلانية المحتوية عليه | |
UA83718C2 (ru) | Кристаллическая форма iv агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит | |
GEP20094576B (en) | New cyrstalline form iii of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
RU2009131727A (ru) | Макроциклические полиморфы, композиции, содержащие такие полиморфы, и способы их применения и получения | |
MY143557A (en) | Beta-crystalline form of perindopril arginine salt, process for its preparation, and pharmaceutical compositions containing it | |
EA200600323A1 (ru) | γd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ | |
HRP20230813T1 (hr) | Upadacitinib solni spoj i postupak njegove pripreme | |
MX2012013332A (es) | Preparacion de intermediarios de posaconazol. | |
EA201000434A1 (ru) | Сокристаллы пириметанила и дитианона | |
MY147951A (en) | Crystalline potassium salt of lipoxin a? analogs | |
RS53001B (sr) | Delta kristalni oblik argininske soli perindoprila, postupak za njegovu proizvodnju i farmaceutske smeše koje ga sadrže | |
EA200900936A1 (ru) | Аморфные и кристаллические формы ривастигмина гидротартрата | |
WO2009000909A8 (en) | Salts of perindopril | |
JO2959B1 (en) | Mono-hydrochloric salts for histone dacetylase inhibitor | |
MY138209A (en) | New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it. | |
TNSN05076A1 (en) | New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it | |
GEP20094652B (en) | New cyrstalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
TH87172B (th) | ผลึกรูปแบบ v ชนิดใหม่ของอะโกเมลาทีน, กรรมวิธีในการเตรียมและองค์ประกอบทางเภสัชกรรมซึ่งมีสารนี้ | |
EA026329B1 (ru) | НОВАЯ ПОЛИМОРФНАЯ МОДИФИКАЦИЯ ДИОСГЕНИЛ-α-L-ПИРАНОЗИЛ-(1->2)-β-D-ГЛЮКОПИРАНОЗИДА |